RxDoctor Payments Data

Richard Benetti, MD

Internal Medicine · Stoneham, MANPI 1174752448

Payments from drug & device makers

$732in general payments, 2019–2025

Across 37 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$150
  • AstraZeneca$90
  • Pfizer$88
  • E.r. Squibb & Sons, L.L.C.$64
  • Lilly USA, LLC$63
  • Takeda Pharmaceuticals U.S.A., Inc.$56
  • plus $221 from 9 others

What the payments were for

  • Food & beverage$732100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$732 in reported general payments places this provider in the 80th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$145,227
Medicare patients
273
Services billed
1,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$63,148
JardianceEmpagliflozin30$40,533
JanuviaSitagliptin Phosphate26$21,536
TrulicityDulaglutide14$16,469
TradjentaLinagliptin13$6,749
Atorvastatin Calcium444$5,701
Wixela InhubFluticasone Propion/Salmeterol38$4,772
Metoprolol Succinate201$3,760
Qvar RedihalerBeclomethasone Dipropionate12$3,051
Rosuvastatin Calcium93$2,849
Omeprazole186$2,623
Pravastatin Sodium121$2,607
Albuterol Sulfate HfaAlbuterol Sulfate90$2,471
Losartan Potassium177$2,379
Lisinopril282$2,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$88$63,14886 claims
MerckJanuvia$27$21,53626 claims
Lilly USA, LLCTrulicity$63$16,46914 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$22$3,05112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,983 internal medicine providers in Massachusetts.

Other internal medicine in Stoneham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →